x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Marketing authorization with orphan designation - USA

  • Tradename: ABRAXANE
  • ATC code : L01CD01
  • EU Number: -
  • MA date : 06/09/2013
  • MA holder: ABRAXIS BIOSCIENCE LIMITED

Therapeutic indication

First-line treatment of patients with metastatic adenocarcinoma of the pancreas, in combination with gemcitabine.

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.